Please use this identifier to cite or link to this item:
Title: Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions
Author: Doherty, Rebecca
Lubinski, Jan
Manguoglu, Esra
Luleci, Guven
Christie, Margaret
Craven, Paul
Bancroft, Elizabeth K.
Mitra, Anita
Morgan, Sarah
Eeles, Rosalind A.
IMPACT Study Steering Committee
Keywords: Càncer de pròstata
Prostate cancer
Medical screening
Issue Date: 15-Mar-2007
Publisher: BioMed Central
Abstract: IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1/2 mutation carriers and controls) is an international collaboration investigating the utility of targeted prostate-specific antigen (PSA) screening for men at increased risk of prostate cancer due to inherited predisposition. Although the majority of prostate cancer occurs sporadically, it is recognized that family history plays a role in a significant number of cases: a family history either of prostate cancer alone, or of other cancers including breast and ovarian cancer. Evidence of the link between single genes and prostate cancer risk is strongest for the BRCA1 and BRCA2 genes, with BRCA2 in particular thought to lead to a relative risk of 4.65 (95%CI 3.48-6.22). This relative risk may be as high as 7.33 in men under the age of 65 years.
Note: Reproducció del document publicat a:
It is part of: Hereditary Cancer in Clinical Practice , 2007, vol. 5, num. 1, p. 53-55
Related resource:
ISSN: 1731-2302
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
565447.pdf65.91 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons